Continuous jugular venous oxygen saturation monitoring after cardiac arrest
Official title: Feasibility and Validation of Continuous Measurement of Jugular Venous Oxygen Saturation in Comatose Patients After Cardiac Arrest
Run by University of Pittsburgh · NCT06511999 · Data updated 2026-11-12
This project will test continuous and intermittent jugular venous oxygen saturation monitoring in adults who are comatose after cardiac arrest to see if brain oxygen delivery patterns can be detected and tracked.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 25 (estimated) |
| Sponsor | University of Pittsburgh Academic / other |
| Locations | 1 site (Pittsburgh, Pennsylvania) |
| Status | Recruiting |
| Started | September 20, 2025 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | June 5, 2026 |
| Trial ID | NCT06511999 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18 years) resuscitated from out-of-hospital or in-hospital cardiac arrest who remain comatose with motor Glasgow Coma Scale ≤4 off sedation for at least 30 minutes are ideal candidates.
✕Probably not a fit
Patients whose cardiac arrest was due to traumatic brain injury, intracranial bleeding, or ischemic stroke, those with unstable cervical spine fractures, extreme hemodynamic instability, moribund neurologic status, pregnancy, or incarceration are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults who achieve return of spontaneous circulation but remain comatose after cardiac arrest will undergo placement of a PediaSat oximetry catheter in the jugular vein to measure jugular venous oxygen saturation (SjO2). Some patients will have continuous SjO2 monitoring while others will have intermittent blood-sample-based measurements using the same catheter and hospital blood gas analysis. This observational protocol will record SjO2 trends alongside standard neurocritical care measures such as targeted temperature management, blood pressure, oxygenation, carbon dioxide targets, and EEG monitoring. The goal is to characterize between-patient heterogeneity in brain oxygen delivery after cardiac arrest to inform potential individualized neuroprotective treatments.
Why it matters
Potential benefit: If successful, this could help clinicians detect episodes of inadequate brain oxygen delivery earlier and tailor treatments to each patient's needs, potentially improving neurologic recovery.
How similar studies have gone: Jugular venous oximetry and other neuromonitoring techniques are used clinically, but there is limited direct evidence that SjO2-guided management improves neurological outcomes after cardiac arrest, so this approach is relatively novel in terms of demonstrated benefit.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: • Adults (\>=18 years old) resuscitated from out-of-hospital or in-hospital cardiac arrest who remain comatose (motor Glasgow coma scale \<=4) for at least 30 minutes when examined off sedation/neuromuscular blockade. Exclusion Criteria: * Cardiac arrest due to traumatic brain injury, intracranial bleeding, or ischemic stroke * Cervical spine fracture * Need for immediate prone positioning for severe hypoxemic respiratory failure * Marked hemodynamic instability precluding priority of any neuromonitoring (multiple recurrent cardiac arrests, norepinephrine equivalents \> 1.5 mcg/kg/min) * Moribund neurological status based upon initial clinical, radiographic and historical assessment (e.g. diffuse cerebral edema or herniation on head computed tomography) * Pregnancy * Prisoners
Where it's running
-
UPMC Presbyterian Hospital
Pittsburgh, Pennsylvania, United States Recruiting
Study contacts
- Principal investigator: Byron Drumheller, MD — University of Pittsburgh
- Study coordinator: Byron Drumheller, MD
- Email: drumhellerbc@upmc.edu
- Phone: 1-301-461-9301
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Heartsight helps caregivers of kids after cardiac arrest manage uncertainty and fear
This pilot trial tests if the Heartsight information program is acceptable and helpful for caregivers of children who recently had a cardiac arrest.
-
Brain blood flow and brain regulation in critically ill kids
This study tests how blood flow in the brain behaves in critically ill children using a noninvasive ultrasound (TCD) to see if brain autoregulation patterns relate to outcomes.
-
Cardiopulmonary resuscitation with balloon occlusion of the descending aorta for hospitalized patients
This trial will test whether adding a balloon occlusion of the descending aorta (REBOA) to standard ACLS helps people having an in-hospital cardiac arrest regain and keep a pulse.
-
Digital serious game to improve critical care nurses' targeted temperature management skills and situational awareness.
We will test whether adding a digital serious game to regular lectures helps adult ICU nurses learn targeted temperature management and improve situational awareness.
-
Plasma proteins, metabolites, and platelet changes in extracorporeal CPR for cardiac arrest patients
This project will test whether patterns in blood proteins, small molecules, and platelet shape changes can help identify which adults with cardiac arrest might benefit from extracorporeal CPR.
-
Targeted Temperature Management at 33°C for in-hospital cardiac arrest
This trial tests whether cooling patients who remain unconscious after a resuscitated in-hospital cardiac arrest to 33°C improves survival with good brain function compared to keeping a normal, controlled temperature.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.